Phase 2–4 trials
Cardiomyopathy & ATTR amyloidosis · Live ClinicalTrials.gov data
Mavacamten (Camzyos) clinical trial pipeline
ClinicalTrials.gov lists 15 phase 2–4 trials for mavacamten (Camzyos), 1 of them actively recruiting. Refreshed daily. Add up to four competitors to compare pipelines side by side.
Phase 3 trials
Actively recruiting
Participants across trials
Lead sponsor by trial count
mavacamten
Upcoming readouts
3 ahead · mavacamten
Key mavacamten trials
Top 12 of the 15 registered phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track mavacamten with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for mavacamten?
- ClinicalTrials.gov currently lists 15 phase 2–4 mavacamten trials: 4 phase 2, 6 phase 3, and 5 phase 4. 1 are actively recruiting.
- Are there clinical trials for Camzyos?
- Camzyos is the brand name for mavacamten, so mavacamten trials on ClinicalTrials.gov cover it. ClinicalTrials.gov currently lists 15 phase 2–4 mavacamten trials: 4 phase 2, 6 phase 3, and 5 phase 4. 1 are actively recruiting.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare mavacamten against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
